HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Usefulness of pindolol in neurocardiogenic syncope.

Abstract
We prospectively studied the efficacy of pindolol, a beta-adrenergic blocker with intrinsic sympathomimetic activity (ISA), for the prevention of syncope recurrences in 31 patients with recurrent neurocardiogenic syncope. Pindolol proved to be an effective treatment, even in patients who had previously failed treatment with conventional beta blockers, suggesting a clinical benefit from addition of ISA to beta blockade in this setting.
AuthorsD Iskos, J Dutton, M M Scheinman, K G Lurie
JournalThe American journal of cardiology (Am J Cardiol) Vol. 82 Issue 9 Pg. 1121-4, A9 (Nov 01 1998) ISSN: 0002-9149 [Print] United States
PMID9817494 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Adrenergic beta-Antagonists
  • Pindolol
Topics
  • Adolescent
  • Adrenergic beta-Antagonists (therapeutic use)
  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pindolol (therapeutic use)
  • Prospective Studies
  • Syncope, Vasovagal (diagnosis, drug therapy, prevention & control)
  • Tilt-Table Test
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: